| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jingting Li | Q56754375 |
| P2093 | author name string | Hui Wang | |
| Dan Xu | |||
| Jie Ping | |||
| Zhang-Xiu Liao | |||
| P2860 | cites work | Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen | Q28205871 |
| Human chemokines: an update | Q28237635 | ||
| The DNA binding protein BTEB mediates acetaldehyde-induced, jun N-terminal kinase-dependent alphaI(I) collagen gene expression in rat hepatic stellate cells | Q28344064 | ||
| Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors | Q28360101 | ||
| DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells | Q28363500 | ||
| Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis | Q28568441 | ||
| Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats | Q28571978 | ||
| Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis | Q28572348 | ||
| Liver fibrosis | Q29547449 | ||
| Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice | Q31132262 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. | Q33904041 | ||
| Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis | Q33984201 | ||
| The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide | Q34063927 | ||
| Krüppel-like factors: three fingers in many pies | Q34083303 | ||
| Cooperation of liver cells in health and disease | Q34103771 | ||
| Cytokine receptors and signaling in hepatic stellate cells | Q34391388 | ||
| Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. | Q35083777 | ||
| The bone marrow functionally contributes to liver fibrosis. | Q51805517 | ||
| A Germline DNA Polymorphism Enhances Alternative Splicing of theKLF6Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk | Q57540252 | ||
| An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis | Q57570913 | ||
| Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor | Q60542057 | ||
| Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats | Q64380601 | ||
| Sp1 binding activity increases in activated Ito cells | Q71846440 | ||
| Kupffer cell–derived 95-kd type IV collagenase/gelatinase B: Characterization and expression in cultured cells | Q71846465 | ||
| Synergism between hepatocytes and Kupffer cells in the activation of fat storing cells (perisinusoidal lipocytes) | Q72756322 | ||
| Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide | Q73043085 | ||
| Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells | Q73322874 | ||
| Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis | Q73330045 | ||
| The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts | Q74531821 | ||
| Molecular regulation of hepatic fibrogenesis | Q77619568 | ||
| Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing | Q77897001 | ||
| DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells | Q78377614 | ||
| The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression | Q78719984 | ||
| Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis | Q80002082 | ||
| Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis | Q80088072 | ||
| Bone marrow-derived stem cells and "plasticity". | Q35191640 | ||
| Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation | Q35750826 | ||
| Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. | Q35763752 | ||
| Fibrotic disease and the T(H)1/T(H)2 paradigm | Q35852270 | ||
| Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells | Q36174278 | ||
| The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis | Q36253127 | ||
| Pattern recognition receptors: a contemporary view on liver diseases. | Q36548470 | ||
| Leptin in the field of hepatic fibrosis: a pivotal or an incidental player? | Q36587716 | ||
| Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses | Q36591648 | ||
| Gliotoxin causes apoptosis and necrosis of rat Kupffer cells in vitro and in vivo in the absence of oxidative stress: exacerbation by caspase and serine protease inhibition | Q37394545 | ||
| Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts | Q38301076 | ||
| Regulation of alpha1(I) collagen messenger RNA decay by interactions with alphaCP at the 3'-untranslated region | Q38344613 | ||
| Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors | Q39807542 | ||
| Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells | Q40023264 | ||
| Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of Ikappabalpha degradation in liver stellate cells | Q40064031 | ||
| Leptin stimulates alpha1(I) collagen expression in human hepatic stellate cells via the phosphatidylinositol 3-kinase/Akt signalling pathway | Q40071517 | ||
| Proteasome inhibition induces hepatic stellate cell apoptosis | Q40324324 | ||
| Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells | Q40444779 | ||
| Cytokines and cellular crosstalk involved in the activation of fat-storing cells | Q40477129 | ||
| Collagenases and liver fibrosis | Q40477146 | ||
| How can transforming growth factor beta be targeted usefully to combat liver fibrosis? | Q40518301 | ||
| The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death | Q40589728 | ||
| Apoptotic body engulfment by a human stellate cell line is profibrogenic. | Q40647924 | ||
| Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species | Q40757681 | ||
| Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. | Q40897756 | ||
| Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. | Q40902696 | ||
| Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis | Q41228197 | ||
| Peroxisome proliferator-activated receptors and hepatic stellate cell activation | Q41758990 | ||
| Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells | Q42005914 | ||
| Attenuated liver fibrosis in the absence of B cells | Q42018300 | ||
| Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology. | Q42805358 | ||
| NF-kappaB inhibits expression of the alpha1(I) collagen gene. | Q42809416 | ||
| JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells | Q43597895 | ||
| Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta | Q43619440 | ||
| Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats | Q43720079 | ||
| TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells | Q43779218 | ||
| Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis | Q43858122 | ||
| Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth | Q44378715 | ||
| Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation. | Q44706857 | ||
| Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells | Q44710999 | ||
| Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice | Q44981280 | ||
| Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis | Q45070082 | ||
| Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion | Q45158832 | ||
| Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats. | Q45200719 | ||
| Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. | Q45212249 | ||
| In pursuit of the "Holy Grail"--stem cells, hepatic injury, fibrogenesis and repair | Q45250495 | ||
| Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF. | Q45862339 | ||
| Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo | Q46195186 | ||
| Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. | Q46581129 | ||
| Rat hepatic stellate cells become retinoid unresponsive during activation | Q46777616 | ||
| SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. | Q50781080 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 419-428 | |
| P577 | publication date | 2008-07-04 | |
| P1433 | published in | Journal of Gastroenterology | Q15764399 |
| P1476 | title | Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies | |
| P478 | volume | 43 |
| Q36577152 | 18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells |
| Q35898018 | A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages |
| Q47115217 | AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M. |
| Q38777796 | Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state. |
| Q38932043 | Adverse outcome pathway development from protein alkylation to liver fibrosis |
| Q59807180 | Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF- and ERK 1/2 Pathways |
| Q42132810 | Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt. |
| Q39221513 | Apoptotic effect of propyl gallate in activated rat hepatic stellate cells |
| Q33903059 | Bone marrow stem cells and liver regeneration |
| Q47246640 | CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma |
| Q39108646 | Capsaicin modulates proliferation, migration, and activation of hepatic stellate cells. |
| Q57807125 | Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer |
| Q53194543 | Ca²⁺/calmodulin-dependent protein kinase II mediates platelet-derived growth factor-induced human hepatic stellate cell proliferation. |
| Q27027703 | Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update |
| Q36521527 | Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth |
| Q53072949 | Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis. |
| Q37899786 | Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family |
| Q28069725 | Distinct Hepatic Macrophage Populations in Lean and Obese Mice |
| Q38099737 | Dual role of microRNAs in NAFLD. |
| Q36259454 | Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis |
| Q41996562 | Environmental peer pressure: CD4+ T cell help in tolerance and transplantation |
| Q47246607 | Estrogen receptor‑β‑dependent effects of saikosaponin‑d on the suppression of oxidative stress‑induced rat hepatic stellate cell activation |
| Q36537659 | Explore the Molecular Mechanism of Apoptosis Induced by Tanshinone IIA on Activated Rat Hepatic Stellate Cells |
| Q34178813 | Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis |
| Q53078393 | Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells. |
| Q34399693 | Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells |
| Q35695401 | Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis |
| Q92059925 | Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease |
| Q39062983 | Hepatic Retinyl Ester Hydrolases and the Mobilization of Retinyl Ester Stores |
| Q26752932 | Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis |
| Q38930049 | Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy |
| Q57114477 | Hepatic stellate cells retain retinoid-laden lipid droplets after cellular transdifferentiation into activated myofibroblasts |
| Q33768416 | Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation. |
| Q40814501 | Identification of PDGF-BB binding to thymosin β4 by chemical cross-linking |
| Q50949495 | In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells: interaction between EPCs and HSCs. |
| Q28833323 | Ionone Derivatives from the Mycelium of Phellinus linteus and the Inhibitory Effect on Activated Rat Hepatic Stellate Cells |
| Q37720220 | Low concentrations of bilirubin inhibit activation of hepatic stellate cells in vitro |
| Q34349428 | Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery |
| Q37859370 | Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions |
| Q91284454 | NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice |
| Q33780124 | Nanotechnology applications for the therapy of liver fibrosis |
| Q37801658 | Non-invasive assessment of liver fibrosis: it is time for laboratory medicine |
| Q35622533 | Novel insights into the function and dynamics of extracellular matrix in liver fibrosis |
| Q38945155 | Ocimum gratissimum is effective in prevention against liver fibrosis in vivo and in vitro |
| Q41267688 | Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1. |
| Q33889261 | Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis |
| Q41569005 | Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells |
| Q35079242 | Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells |
| Q28076863 | Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth Factors |
| Q24626209 | Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells |
| Q37462008 | Retinol binding protein-albumin domain III fusion protein deactivates hepatic stellate cells |
| Q89104306 | Role of cAMP and phosphodiesterase signaling in liver health and disease |
| Q37193215 | Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4 |
| Q35780081 | Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis |
| Q50198283 | The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-Beta 1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients |
| Q38038612 | The biological roles of ITGB4BP and its potential effect on fibrosis |
| Q38955273 | The interplay between apoptosis, mitophagy and mitochondrial biogenesis induced by resveratrol can determine activated hepatic stellate cells death or survival |
| Q38129709 | The role of chemokines in acute and chronic hepatitis C infection |
| Q38723669 | The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). |
| Q45716004 | Therapeutic effects of hepatocyte growth factor-overexpressing dental pulp stem cells on liver cirrhosis in a rat model |
| Q37694585 | Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes |
| Q34985947 | Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. |
| Q38497300 | Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays |
| Q89699738 | YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling |
| Q24606657 | miRNA studies in in vitro and in vivo activated hepatic stellate cells |
Search more.